[Numero 68. Maggio 2014] Rivista “STROKE”: Fibrillazione atriale e rischio di emorragia intracranica: preferibile trattamento con rivaroxaban che con warfarin

Articolo di riferimento:

Hankey GJ, Stevens SR, Piccini JP, et al.
Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor xa inhibition compared with vitamin k antagonism for prevention of stroke and embolism trial in atrial fibrillation.
Stroke, 2014;45(5):1304-12.
Leggi l’articolo